Outcomes and Quality of Life After Resorbable Synthetic Ventral Hernia Repair in Contaminated Fields
- PMID: 38556666
- DOI: 10.1097/SAP.0000000000003860
Outcomes and Quality of Life After Resorbable Synthetic Ventral Hernia Repair in Contaminated Fields
Abstract
Introduction: The ideal mesh type for hernia repair in a contaminated field remains controversial. Data regarding outcomes beyond 1 year and the impact on quality of life (QoL) are unknown. This study aims to evaluate the long-term surgical outcomes and patient-reported outcomes (PROs) after contaminated repair with poly-4-hydroxybutyrate (P4HB) mesh.
Materials methods: Patients undergoing a contaminated hernia repair with P4HB between 2015 and 2020 were identified. Surgical site occurrences and hernia recurrences were recorded. Long-term PROs as defined by the Abdominal Hernia-Q and Hernia-Related Quality-of-Life Survey were assessed.
Results: Fifty-five patients were included with a mean age of 54.5 years, a body mass index of 34 kg/m2, and a defect size of 356.9 ± 227.7 cm2. Median follow-up time was 49 months with a reoperation rate of 14.5% and a hernia recurrence rate of 7.3%. Of the 55 patients, 37 completed preoperative and postoperative PRO questionnaires. When comparing preoperative with postoperative Abdominal Hernia-Q, there was significant improvement in overall PROs (2.1 vs 3.5, P < 0.001). This improvement was maintained with no significant changes between postoperative scores over the course of 5 years. Patients with complications saw the same improvement in postoperative PRO scores as those without complications.
Conclusions: Our study found a low hernia recurrence and acceptable long-term reoperation rates in patients undergoing hernia repair with P4HB mesh in a contaminated setting. We demonstrate a sustained significant improvement in QoL scores after hernia repair. These data yield insight into the long-term outcomes and QoL improvement, providing physicians further knowledge to better counsel their patients.
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Conflicts of interest and sources of funding: Dr Fischer has received consulting payments from 3M; AbbVie; Baxter; Becton, Dickinson and Co; WL Gore; and Integra Life Sciences. He has received research support from the National Institutes of Health. No support was provided for this work.
References
-
- Baylón K, Rodríguez-Camarillo P, Elías-Zúñiga A, et al. Past, present and future of surgical meshes: a review. Membranes (Basel). 2017;7:47.
-
- Messa CA, Kozak G, Broach RB, et al. When the mesh goes away: an analysis of poly-4-hydroxybutyrate mesh for complex hernia repair. Plast Reconstr Surg Glob Open. 2019;7:e2576.
-
- Carbonell AM, Criss CN, Cobb WS, et al. Outcomes of synthetic mesh in contaminated ventral hernia repairs. J Am Coll Surg. 2013;217:991–998.
-
- Berríos-Torres SI, Umscheid CA, Bratzler DW, et al. Centers for Disease Control and Prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg. 2017;152:784–791.
-
- Seidelman J, Anderson DJ. Surgical site infections. Infect Dis Clin North Am. 2021;35:901–929.
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
